SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksForterra Regulatory News (FORT)

Share Price Information for Forterra (FORT)

Share Price is delayed by 15 minutes
Get Live Data
130.20    2.40 (1.88%)
Bid:
130.00
Ask:
130.40
Spread: 0.40 (0.308%)
Market Cap: £268.15m
FORT Live PriceLast checked at - London Stock Exchange

Intraday Forterra Share Chart

Trading Statement

26 Jan 2021 07:00

RNS Number : 8095M
Forterra plc
26 January 2021
 

26 January 2021

FORTERRA PLC

TRADING STATEMENT

Forterra plc, a leading UK producer of manufactured masonry products, provides this trading update for the year ended 31 December 2020.

Current Trading & Year End Results

Our current priority remains ensuring the health, safety and wellbeing of our employees through the ongoing pandemic. Our factories remain open, operating in accordance with COVID-19 protocols, and we continue to supply our customers who, under current lockdown restrictions, remain fully operational.

We are pleased to report that the strong trading seen through September and October continued through to the end of the year, exceeding our expectations. Brick and Block revenues for November and December combined were 6% higher than the corresponding prior year period taking full year Group revenues to approximately £290m.

Accordingly, we expect to report 2020 EBITDA and PBT (both stated before exceptional items) of approximately £37m (an increase on our previous guidance of at least £34m) and £16m respectively.

We ended the year with a better than expected liquidity position with net cash of approximately £15m (stated before IFRS 16 lease liabilities) demonstrating our successful management of working capital but also reflecting some rephasing of payments on the Desford project. As at 31 December 2020 the Group had access to committed credit facilities of £170m of which £155m was undrawn.

Desford Brick Factory Construction

Project spend in 2020 amounted to £20m bringing the total to approximately £32m against the project budget of £95m. Following the previously reported insolvency of a major supplier, and after a comprehensive retendering and selection process, contracts for the supply and installation of the manufacturing equipment were signed in January. The planned commissioning of the factory remains on track for late 2022.

Outlook

Looking ahead, the steady improvement in trading through the second half of 2020, along with recent positive statements from our customers, provides growing cause for optimism, although uncertainty remains. The impact of the current Stamp Duty holiday coupled with the impending tapering of the Help to Buy scheme on underlying patterns of demand is unclear. Additionally, the wider economic implications of the UK's new trading relationship with the EU and the longer-term economic impact of the COVID-19 pandemic remain uncertain.

The Board continues to closely monitor both our markets and the wider economy and believes that the Group remains well-placed to benefit from a sustained recovery of our key markets with a structural under supply of housing in the UK expected to continue supporting long-term demand. In the shorter term, the strength of our balance sheet offers resilience against any further challenges ahead. 

We intend to issue our full year results announcement on 9 March 2021.

This announcement contains inside information for the purposes of article 7 of the Market Abuse Regulation (EU) No 596/2014.

ENQUIRIES

Forterra plc +44 1604 707 600

Stephen Harrison, Chief Executive Officer

Ben Guyatt, Chief Financial Officer

FTI Consulting +44 203 727 1340

Richard Mountain / Nick Hasell

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTEASFSAEAFEFA
Date   Source Headline
20th Jan 20267:00 amRNSEmployee Benefit Trust Share Purchase
7th Jan 20269:39 amRNSEmployee Benefit Trust Share Purchase
2nd Dec 20259:22 amRNSEmployee Benefit Trust Share Purchase
24th Nov 20259:03 amRNSHolding(s) in Company
20th Nov 20259:13 amRNSHolding(s) in Company
18th Nov 20255:03 pmRNSEmployee Benefit Trust Share Purchase
11th Nov 20257:00 amRNSTrading Update
4th Nov 20254:34 pmRNSEmployee Benefit Trust Share Purchase
24th Oct 20251:36 pmRNSHolding(s) in Company
23rd Oct 20251:21 pmRNSDirector/PDMR Shareholding
17th Oct 20259:58 amRNSEmployee Benefit Trust Share Purchase
14th Oct 20259:06 amRNSHolding(s) in Company
13th Oct 202510:15 amRNSEmployee Benefit Trust Share Purchase
2nd Oct 20252:54 pmRNSGrant of Options under 2025 SAYE Scheme
11th Aug 20251:15 pmRNSHolding(s) in Company
29th Jul 20257:38 amRNS-RProgressive publishes new research
29th Jul 20257:00 amRNSSix months ended 30 June 2025
23rd Jul 202510:05 amRNSHolding(s) in Company
19th Jun 20257:05 amRNSDirector Declaration
20th May 20251:47 pmRNSAnnual General Meeting 2025 Results
20th May 20257:43 amRNS-RProgressive publishes new research
20th May 20257:00 amRNSAGM Trading Update
13th May 202510:36 amRNSHolding(s) in Company
11th Apr 20259:18 amRNSDirector / PCA Shareholdings
2nd Apr 20252:22 pmRNSDirector/PDMR Shareholding
26th Mar 20255:53 pmRNSAnnual Report & Accounts 2024 & Notice of AGM 2025
25th Mar 20251:47 pmRNSDirector/PDMR Shareholding
20th Mar 20252:44 pmRNSHolding(s) in Company
20th Mar 20257:00 amRNSGrant under Performance Share Plan
20th Mar 20257:00 amRNSGrant under Deferred Annual Bonus Plan
18th Mar 20252:23 pmRNSHolding(s) in Company
12th Mar 20258:14 amRNS-RProgressive publishes new research
12th Mar 20257:00 amRNSFull Year Results
6th Mar 20257:00 amRNSAppointment of Independent Non-Executive Director
27th Feb 20253:35 pmRNSHolding(s) in Company
26th Feb 20252:50 pmRNSHolding(s) in Company
4th Feb 20257:00 amRNSDirectorate Change
23rd Jan 20257:00 amRNSFull Year 2024 Trading Update
6th Jan 20259:23 amRNSHolding(s) in Company
2nd Jan 202511:38 amRNSDirector/PDMR Shareholding
11th Nov 20247:00 amRNSTrading update to the end of the October
4th Nov 202410:24 amRNSHolding(s) in Company
30th Oct 20244:54 pmRNSHolding(s) in Company
28th Oct 202411:51 amRNSHolding(s) in Company
2nd Oct 20245:35 pmRNSGrant of Options under 2024 SAYE Scheme
11th Sep 20247:00 amRNSDirectorate Change
5th Sep 202411:49 amRNSHolding(s) in Company
2nd Sep 20249:59 amRNSHolding(s) in Company
12th Aug 20243:03 pmRNSHolding(s) in Company
30th Jul 20247:00 amRNSSix months ended 30 June 2024

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.